Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.
2.

Musculoskeletal and overgrowth syndromes associated with cutaneous abnormalities.

Dasgeb B, Morris MA, Ring CM, Mehregan D, Mulligan ME.

Br J Radiol. 2016 Nov;89(1067):20160521. Epub 2016 Sep 16. Review.

3.

Clinical Usefulness of Aripiprazole and Lamotrigine in Schizoaffective Presentation of Tuberous Sclerosis.

Lee SY, Min JA, Lee IG, Kim JJ.

Clin Psychopharmacol Neurosci. 2016 Aug 31;14(3):305-10. doi: 10.9758/cpn.2016.14.3.305.

4.

Clinical Electroencephalographic Biomarker for Impending Epilepsy in Asymptomatic Tuberous Sclerosis Complex Infants.

Wu JY, Peters JM, Goyal M, Krueger D, Sahin M, Northrup H, Au KS, Cutter G, Bebin EM.

Pediatr Neurol. 2016 Jan;54:29-34. doi: 10.1016/j.pediatrneurol.2015.09.013. Epub 2015 Sep 25.

5.

Visual Evoked Potentials as a Readout of Cortical Function in Infants With Tuberous Sclerosis Complex.

Varcin KJ, Nelson CA 3rd, Ko J, Sahin M, Wu JY, Jeste SS.

J Child Neurol. 2016 Feb;31(2):195-202. doi: 10.1177/0883073815587328. Epub 2015 May 26.

6.

Autism spectrum disorder and epilepsy: Disorders with a shared biology.

Lee BH, Smith T, Paciorkowski AR.

Epilepsy Behav. 2015 Jun;47:191-201. doi: 10.1016/j.yebeh.2015.03.017. Epub 2015 Apr 19. Review.

7.

Mechanisms regulating neuronal excitability and seizure development following mTOR pathway hyperactivation.

Lasarge CL, Danzer SC.

Front Mol Neurosci. 2014 Mar 14;7:18. doi: 10.3389/fnmol.2014.00018. eCollection 2014. Review.

8.

Fetal brain mTOR signaling activation in tuberous sclerosis complex.

Tsai V, Parker WE, Orlova KA, Baybis M, Chi AW, Berg BD, Birnbaum JF, Estevez J, Okochi K, Sarnat HB, Flores-Sarnat L, Aronica E, Crino PB.

Cereb Cortex. 2014 Feb;24(2):315-27. doi: 10.1093/cercor/bhs310. Epub 2012 Oct 18.

9.

Atypical presentation of renal angiomyolipomas in a child with tuberous sclerosis complex.

Ferrara P, Romano V, Gatto A, Vitelli O, Liberatore P, Passera S, Bottaro G, Del Bufalo F, Martinelli D, Del Re M, Battaglia D.

Iran J Pediatr. 2011 Jun;21(2):256-7. No abstract available.

10.

Drosophila cancer models.

Rudrapatna VA, Cagan RL, Das TK.

Dev Dyn. 2012 Jan;241(1):107-18. doi: 10.1002/dvdy.22771. Epub 2011 Oct 28. Review.

11.

Enhanced GABAergic network and receptor function in pediatric cortical dysplasia Type IIB compared with Tuberous Sclerosis Complex.

Cepeda C, André VM, Hauptman JS, Yamazaki I, Huynh MN, Chang JW, Chen JY, Fisher RS, Vinters HV, Levine MS, Mathern GW.

Neurobiol Dis. 2012 Jan;45(1):310-21. doi: 10.1016/j.nbd.2011.08.015. Epub 2011 Aug 23.

12.

Lymphangioleiomyomatosis: what do we know and what are we looking for?

Harari S, Torre O, Moss J.

Eur Respir Rev. 2011 Mar;20(119):34-44. doi: 10.1183/09059180.00011010. Review.

13.

Enhanced epidermal growth factor, hepatocyte growth factor, and vascular endothelial growth factor expression in tuberous sclerosis complex.

Parker WE, Orlova KA, Heuer GG, Baybis M, Aronica E, Frost M, Wong M, Crino PB.

Am J Pathol. 2011 Jan;178(1):296-305. doi: 10.1016/j.ajpath.2010.11.031. Epub 2010 Dec 23.

14.

Comparative study of cellular and synaptic abnormalities in brain tissue samples from pediatric tuberous sclerosis complex and cortical dysplasia type II.

Cepeda C, André VM, Yamazaki I, Hauptman JS, Chen JY, Vinters HV, Mathern GW, Levine MS.

Epilepsia. 2010 Jul;51 Suppl 3:160-5. doi: 10.1111/j.1528-1167.2010.02633.x.

15.

Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies.

Wong M.

Epilepsia. 2010 Jan;51(1):27-36. doi: 10.1111/j.1528-1167.2009.02341.x. Epub 2009 Oct 8. Review.

16.

Abnormal glutamate homeostasis and impaired synaptic plasticity and learning in a mouse model of tuberous sclerosis complex.

Zeng LH, Ouyang Y, Gazit V, Cirrito JR, Jansen LA, Ess KC, Yamada KA, Wozniak DF, Holtzman DM, Gutmann DH, Wong M.

Neurobiol Dis. 2007 Nov;28(2):184-96. Epub 2007 Jul 21.

17.

The natural history and treatment of epilepsy in a murine model of tuberous sclerosis.

Erbayat-Altay E, Zeng LH, Xu L, Gutmann DH, Wong M.

Epilepsia. 2007 Aug;48(8):1470-6. Epub 2007 May 1.

18.

Molecular pathogenesis of lymphangioleiomyomatosis: lessons learned from orphans.

Juvet SC, McCormack FX, Kwiatkowski DJ, Downey GP.

Am J Respir Cell Mol Biol. 2007 Apr;36(4):398-408. Epub 2006 Nov 10. Review.

19.

Rare lung diseases I--Lymphangioleiomyomatosis.

Juvet SC, Hwang D, Downey GP.

Can Respir J. 2006 Oct;13(7):375-80. Review.

20.

TSC2 modulates actin cytoskeleton and focal adhesion through TSC1-binding domain and the Rac1 GTPase.

Goncharova E, Goncharov D, Noonan D, Krymskaya VP.

J Cell Biol. 2004 Dec 20;167(6):1171-82.

Supplemental Content

Support Center